|
Market Closed -
Nasdaq
01:30:00 21/05/2025 am IST
|
5-day change | 1st Jan Change | ||
| 9.600 USD | -1.13% |
|
-.--% | - |
| 23/25/23 | OptiNose, Inc.(NasdaqGS:OPTN) dropped from S&P Global BMI Index | CI |
| 23/25/23 | OptiNose, Inc.(NasdaqGS:OPTN) dropped from S&P TMI Index | CI |
| Market Cap | 9.72Cr 8.63Cr 8.09Cr 7.32Cr 14Cr 936.84Cr 14Cr 97Cr 38Cr 477.85Cr 36Cr 36Cr 1.54TCr | P/E 2023 |
-4.07x | P/E 2024 | -3.15x |
|---|---|---|---|---|---|
| Enterprise Value | 14Cr 13Cr 12Cr 11Cr 20Cr 1.37TCr 20Cr 141.5Cr 55Cr 696.45Cr 53Cr 52Cr 2.24TCr | EV / Sales 2023 |
2.86x | EV / Sales 2024 | 1.43x |
| Free-Float |
6.21% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | -1.13% |
| 3 years | 4.81 |  | 31.5 |
| 5 years | 4.81 | | 64.5 |
| 10 years | 4.81 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Evan Loh
CEO | Chief Executive Officer | 67 | 21/05/2025 |
| Chief Tech/Sci/R&D Officer | - | 01/01/2020 | |
Jonathan Neely
IRC | Investor Relations Contact | - | 01/08/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Evan Loh
BRD | Director/Board Member | 67 | 21/05/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/05/25 | Issuer sale | Chief Executive Officer | 4,52,016 | 4.4953% | ||
| 21/05/25 | Issuer sale | Chief Financial Officer | 82,491 | 0.8204% | ||
| 21/05/25 | Issuer sale | Director | 12,624 | 0.1255% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.13% | -.--% | -.--% | -49.00% | 9.72Cr | |
| +1.26% | -2.30% | +37.82% | +113.76% | 1,01900Cr | |
| +0.73% | -6.31% | +35.06% | +62.14% | 61TCr | |
| +0.35% | +0.15% | +14.01% | +80.87% | 47TCr | |
| +1.72% | -4.54% | +59.14% | +37.01% | 34TCr | |
| +0.26% | -1.58% | +21.97% | +41.79% | 34TCr | |
| +0.60% | -3.48% | +11.37% | +34.33% | 27TCr | |
| +1.65% | -4.27% | -5.47% | +9.69% | 24TCr | |
| -0.09% | -3.71% | +35.15% | +51.88% | 22TCr | |
| -0.28% | -5.24% | +27.99% | +93.08% | 18TCr | |
| Average | +0.06% | -3.26% | +23.70% | +47.55% | 36.83TCr | |
| Weighted average by Cap. | +0.16% | -3.51% | +29.49% | +70.06% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 7.1Cr 6.3Cr 5.9Cr 5.35Cr 10Cr 684.03Cr 10Cr 71Cr 28Cr 348.9Cr 27Cr 26Cr 1.12TCr | 7.82Cr 6.95Cr 6.51Cr 5.89Cr 11Cr 753.79Cr 11Cr 78Cr 30Cr 384.48Cr 29Cr 29Cr 1.24TCr |
| Net income | -3.55Cr -3.15Cr -2.95Cr -2.67Cr -5.04Cr -341.91Cr -5.08Cr -35Cr -14Cr -174.4Cr -13Cr -13Cr -561.2Cr | -2.15Cr -1.91Cr -1.79Cr -1.62Cr -3.06Cr -207.57Cr -3.09Cr -22Cr -8.36Cr -105.87Cr -8.09Cr -7.91Cr -340.69Cr |
| Net Debt | 5.81Cr 5.16Cr 4.83Cr 4.37Cr 8.25Cr 559.51Cr 8.32Cr 58Cr 23Cr 285.39Cr 22Cr 21Cr 918.35Cr | 4.45Cr 3.95Cr 3.7Cr 3.35Cr 6.32Cr 428.57Cr 6.37Cr 44Cr 17Cr 218.6Cr 17Cr 16Cr 703.43Cr |
Employees
128
Sector
Pharmaceuticals
- Stock Market
- Stocks
- OPTN Stock
Select your edition
All financial news and data tailored to specific country editions
